Nanomix Inc (Nanomix) carries out the development of mobile point-of-care (POC) diagnostics. The company's activities include creating handheld testing platforms and assays that provide rapid, accurate and quantitative information for use in critical clinical decision-making and patient care. Its product is the Nanomix eLab System, a mobile diagnostic tool designed to deliver critical diagnostic information at the point of Initial patient interaction. Nanomix's products are used in various settings such as hospitals, nursing facilities, elderly homes, urgent care centers, airports, and schools. The company has formed collaborations with entities like World Technology East 2 and RedPharm Biotechnology Ltd for the use and deployment of its products and technology. Nanomix is headquartered in San Leandro, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Nanomix Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Nanomix Inc Company Overview
- Nanomix Inc Company Snapshot
- Nanomix Inc Pipeline Products and Ongoing Clinical Trials Overview
- Nanomix Inc - Pipeline Analysis Overview
- Nanomix Inc - Key Facts
- Nanomix Inc - Major Products and Services
- Nanomix Inc Pipeline Products by Development Stage
- Nanomix Inc Pipeline Products Overview
- CapLite
- CapLite Product Overview
- eLab Acute Kidney Injury Test
- eLab Acute Kidney Injury Test Product Overview
- eLab COVID-19 Rapid Antigen Panel
- eLab COVID-19 Rapid Antigen Panel Product Overview
- eLab Critical Cardiac Test
- eLab Critical Cardiac Test Product Overview
- eLab Stroke Test
- eLab Stroke Test Product Overview
- eLab Traumatic Brain Injury Test
- eLab Traumatic Brain Injury Test Product Overview
- Nanomix Asthma Management System
- Nanomix Asthma Management System Product Overview
- Nanomix eLab Rapid Test - Fever
- Nanomix eLab Rapid Test - Fever Product Overview
- Nanomix eLab System
- Nanomix eLab System Product Overview
- Nanomix eLab System - COVID-19 Circulating Antibodies
- Nanomix eLab System - COVID-19 Circulating Antibodies Product Overview
- Nanomix eLab SARS-CoV-2 Antibody Cartridge
- Nanomix eLab SARS-CoV-2 Antibody Cartridge Product Overview
- Omega-3 Cardiac Panel
- Omega-3 Cardiac Panel Product Overview
- Nanomix Inc - Key Competitors
- Nanomix Inc - Key Employees
- Nanomix Inc - Locations And Subsidiaries
- Head Office
- Recent Developments
- Nanomix Inc, Recent Developments
- Nov 29, 2022: Nanomix enters into distribution agreement for the eLab system with Gepa in Italy
- Oct 20, 2022: Nanomix enters into distribution agreement for the eLab system with Diaclinic SpA in Chile
- Sep 12, 2022: Nanomix enters into distribution agreement for the eLab system and future new products with IPS Genomix s.a.l. in the Middle East
- Sep 05, 2022: Nanomix and Mobility Health to develop test for Covid-19 antibodies
- Aug 23, 2022: Nanomix enters into Distribution Agreement for the eLab System and future new products with BIOASIA PTE LTD in Singapore
- Jul 21, 2022: Nanomix announces distribution agreement for the eLab system with Biotron in Israel
- Jun 22, 2022: Nanomix initiates new clinical study for the eLab S1 panel
- Jun 14, 2022: Nanomix receives IVDR certification for the eLab analyzer
- May 26, 2022: Nanomix granted CE mark for eLab S1 Assay panel for whole blood samples
- May 23, 2022: Nanomix’s Covid-19 rapid antigen test obtains CE mark
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- Nanomix Inc Pipeline Products and Ongoing Clinical Trials Overview
- Nanomix Inc Pipeline Products by Equipment Type
- Nanomix Inc Pipeline Products by Indication
- Nanomix Inc, Key Facts
- Nanomix Inc, Major Products and Services
- Nanomix Inc Number of Pipeline Products by Development Stage
- Nanomix Inc Pipeline Products Summary by Development Stage
- CapLite - Product Status
- CapLite - Product Description
- eLab Acute Kidney Injury Test - Product Status
- eLab Acute Kidney Injury Test - Product Description
- eLab COVID-19 Rapid Antigen Panel - Product Status
- eLab COVID-19 Rapid Antigen Panel - Product Description
- eLab Critical Cardiac Test - Product Status
- eLab Critical Cardiac Test - Product Description
- eLab Stroke Test - Product Status
- eLab Stroke Test - Product Description
- eLab Traumatic Brain Injury Test - Product Status
- eLab Traumatic Brain Injury Test - Product Description
- Nanomix Asthma Management System - Product Status
- Nanomix Asthma Management System - Product Description
- Nanomix eLab Rapid Test - Fever - Product Status
- Nanomix eLab Rapid Test - Fever - Product Description
- Nanomix eLab System - Product Status
- Nanomix eLab System - Product Description
- Nanomix eLab System - COVID-19 Circulating Antibodies - Product Status
- Nanomix eLab System - COVID-19 Circulating Antibodies - Product Description
- Nanomix eLab SARS-CoV-2 Antibody Cartridge - Product Status
- Nanomix eLab SARS-CoV-2 Antibody Cartridge - Product Description
- Omega-3 Cardiac Panel - Product Status
- Omega-3 Cardiac Panel - Product Description
- Nanomix Inc, Key Employees
- Glossary
- Nanomix Inc Pipeline Products by Equipment Type
- Nanomix Inc Pipeline Products by Development Stage
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Sekisui Diagnostics LLC
- Medtronic Inc
- BioMedomics Inc
- Sekisui Diagnostics LLC
- Medtronic Inc
- BioMedomics Inc
